Renal, Fluids, Electrolytes & Acid-Base · Topic 17 of 22

Phosphate Disorders

Renal · electrolytes

Phosphate Disorders

Phosphate falls when cells take it up — refeeding, insulin for DKA — and rises when kidneys fail or cells burst. Give IV phosphate below 1 mg/dL.

Key numbers

Normal phosphate 2.5–4.5 mg/dLPO₄ < 1 mg/dL = severe

IV phosphate below 1 mg/dLIV if PO₄ < 1 mg/dL

Calcium × phosphate product over 55 calcifiesCa × PO₄ > 55

01 · The numberNormal phosphate 2.5–4.5 mg/dL

Normal adult serum phosphate is 2.5–4.5 mg/dL; hypophosphatemia is below 2.5 mg/dL — mild 2–2.5, moderate 1–2, severe below 1 mg/dL (0.32 mmol/L) — and hyperphosphatemia is above 4.5 mg/dL.

02 · DoIV phosphate below 1 mg/dL

Give IV phosphate when serum phosphate is below 1 mg/dL, with rhabdomyolysis, hemolysis or CNS symptoms, or when oral intake is impossible; otherwise treat the cause and give oral phosphate.

03 · CauseHigh phosphate: kidney failure, tumor lysis, rhabdomyolysis

Hyperphosphatemia is usually reduced renal excretion — GFR below 30 mL/min — or hypoparathyroidism; massive cell release (tumor lysis syndrome, rhabdomyolysis, crush injury) or phosphate laxatives and enemas can overwhelm excretion.

Causes & risk factors

Why it happens

Acute low phosphate: refeeding, DKA treatment, alcohol must knowClinically significant acute hypophosphatemia occurs in refeeding after undernutrition, parenteral nutrition, the recovery (insulin) phase of DKA, alcohol use disorder, severe burns and severe respiratory alkalosis — mostly intracellular shifts on top of depletion.

Presentation

What you'll see

Severe hypophosphatemia: weakness, respiratory failure, hemolysisSevere hypophosphatemia causes muscle weakness and respiratory failure, heart failure, rhabdomyolysis, hemolytic anemia, impaired oxygen release from hemoglobin, leukocyte and platelet dysfunction, encephalopathy, seizures and coma.

Hyperphosphatemia symptoms come from low calciumMost hyperphosphatemia is asymptomatic; symptoms such as tetany come from accompanying hypocalcemia, and chronic elevation drives secondary hyperparathyroidism and renal osteodystrophy in CKD.

Diagnosis & monitoring

Work-up

Infuse phosphate slowly; monitor calcium and phosphateGive IV phosphate slowly (usually over about 6 hours) and monitor serum calcium and phosphate, especially with impaired renal function; rapid infusion causes hypocalcemia, hyperphosphatemia and metastatic calcification.

Do right now

In this order

First moves

IV phosphate below 1 mg/dLIV if PO₄ < 1 mg/dL

→

Infuse phosphate slowly; monitor calcium and phosphate

→

Acute hyperphosphatemia: saline diuresis or hemodialysis

Why each step

IV phosphate below 1 mg/dLGive IV phosphate when serum phosphate is below 1 mg/dL, with rhabdomyolysis, hemolysis or CNS symptoms, or when oral intake is impossible; otherwise treat the cause and give oral phosphate.

Acute hyperphosphatemia: saline diuresis or hemodialysisFor acute hyperphosphatemia with intact kidney function, saline diuresis increases phosphate excretion; hemodialysis lowers phosphate in severe acute cases.

Management

Orders

Lower phosphate with binders taken with meals must knowIn advanced CKD treat hyperphosphatemia with dietary phosphate restriction plus binders taken with meals: calcium carbonate or acetate, or calcium-free sevelamer (800–2400 mg three times daily) or lanthanum.

Potassium phosphate unless K⁺ high or renal impairmentIV potassium phosphate is safe with good renal function; use sodium phosphate if renal function is impaired or potassium exceeds 4 mEq/L. IV potassium phosphate adds about 1.5 mEq potassium per mmol phosphate.

DKA: no routine phosphate replacementPhosphate falls during DKA treatment, but randomized trials show no benefit from routine replacement; replace when it is severely low with respiratory or cardiac compromise, adding 20–30 mmol potassium phosphate to fluids, and watch calcium.

Red flags & don'ts

Avoid harm

Calcium × phosphate product over 55 calcifies complicationA calcium × phosphate product chronically above 55 mg²/dL² in CKD precipitates calcium phosphate in skin and vessels, causing pruritus, nodules and vascular calcification that raises stroke and MI risk.

No aluminum binders in end-stage kidney disease avoidDo not use aluminum-containing antacids as phosphate binders in end-stage kidney disease (aluminum dementia and osteomalacia); monitor the calcium × phosphate product when using calcium-based binders in dialysis patients.

Low or high phosphate?

Commonly confused

Serum level	< 2.5 mg/dL (severe < 1)
Classic acute setting	Refeeding, DKA treatment, alcohol use, burns
What harms the patient	Weakness, respiratory failure, rhabdomyolysis, hemolysis, seizures
Treatment	Oral phosphate; IV if < 1 mg/dL or severe symptoms

Commonly confused

Tell apart

DKA: high phosphate on arrival, deficit underneathDKA can present with hyperphosphatemia from a transcellular shift despite total-body phosphate depletion; insulin and fluids then drive serum phosphate down.

More detail

Reference

Show 5 reference facts

Chronic hypophosphatemia usually reflects decreased renal reabsorption: hyperparathyroidism, vitamin D deficiency, hypomagnesemia, hypokalemia, long-term diuretics, or prolonged aluminum or dialysis phosphate binders with low intake.

Oral phosphate (up to about 1 g three times daily as sodium or potassium phosphate) often causes diarrhea; 1 L of low-fat or skim milk provides about 1 g and may be better tolerated.

Spurious hyperphosphatemia occurs with paraproteinemia (myeloma, macroglobulinemia), hyperlipidemia, hemolysis and hyperbilirubinemia; when the cause is unclear, evaluate for hypoparathyroidism or pseudohypoparathyroidism.

Other calcium-free binders for dialysis patients: lanthanum carbonate 500–1000 mg and sucroferric oxyhydroxide 500 mg, each three times daily with meals.

Refeeding a malnourished patient drops phosphate, potassium and magnesium as insulin drives them into cells; see the Refeeding Syndrome and Tumor Lysis Syndrome topics for risk screening and prevention.

Pearl

The DKA patient arrives with a normal or high phosphate and a body-wide deficit — insulin unmasks it.

Sources · Merck Manual Professional — Hypophosphatemia (updated Dec 2025) · Merck Manual Professional — Hyperphosphatemia (updated Dec 2025) · Merck Manual Professional — Overview of Disorders of Phosphate Concentration · Merck Manual Professional — Acute Complications of Diabetes Mellitus (DKA: phosphate repletion and calcium monitoring) · Umpierrez GE et al. Hyperglycaemic crises in adults with diabetes: a consensus report (ADA/EASD/JBDS/AACE/DTS). Diabetologia 2024, doi 10.1007/s00125-024-06183-8 (also Diabetes Care 2024;47:1257–1275) · Starter sheet built from the verified AGACNP fact map (facts reviewed 2026-10-15).